ERBA Diagnostics (ERB) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ERBA Diagnostics, Inc. Reports 2014 Financial Results; Announces Delay in Filing Quarterly Report on Form 10-Q
May 18, 2015 7:00 AM EDTMIAMI LAKES, Fla., May 18, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, reported its financial results for the year ended December 31, 2014. Net income for the year ended December 31, 2014 was $450,000, compared to net income of $676,000 for the year ended December 31, 2013. Net revenues for the year ended December 31, 2014 were $26,392,000, compared to net revenues of $28,255,000 for the year ended December 31, 2013.
"2014 was a year of consolidation for ERBA Diagnostics, during which time we maintained profitability and set the stage for future top and bottom line growth," said Mohan Gopalkrishnan, Chief... More
